Zetta Genomics

Executive Summary

Zetta Genomics is a UK-based bioinformatics company that offers XetaBase, a cloud-native platform for managing, analyzing, and sharing large-scale genomic and clinical data. Founded in 2019 and spun out from the University of Cambridge, the company leverages expertise from the Genomics England 100,000 Genomes Project. XetaBase enables efficient real-time querying and data processing for both research and clinical applications, addressing the growing need for scalable genomic data infrastructure. While Zetta Genomics has not disclosed funding amounts or valuation, its origins and focus on the UK genomics market position it well for potential partnerships with healthcare providers and research institutions. The company operates in the competitive genetics and genomics space, with opportunities to differentiate through its cloud-native architecture and integration capabilities.

Upcoming Catalysts (preview)

• Q3 2026Partnership with NHS for Genomic Data Management40% success
• H2 2026Series A Funding Round Announcement50% success
• Q4 2026Launch of New AI-Powered Analytics Module60% success